Thomas Mika

Thomas Mika joined POET in November 2016. He previously served as the chairman of the board of Rennova Health, the successor company to CollabRx and previously Tegal Corporation. Following Tegal's spin-out from Motorola in 1989, Mr. Mika assumed the roles of CFO in 2002, CEO in 2005, and Chairman and CEO in 2006. Previously, he co-founded IMTEC, a boutique investment and consulting firm, serving international clients over a period of 20 years. Mr. Mika holds a Bachelor of Science in Microbiology from the University of Illinois at Urbana-Champaign and a Master of Business Administration from the Harvard Graduate School of Business.